P-001 30-Day Readmission After Ileal Pouch Anal Anastomosis Surgery: A Report From ACS-NSQIP Database Aydinli H. Hande1, Lynn Patricio1, Aytac Erman2, Grieco Michael1, Remzi Feza3 1NYU Langone Medical Center, New York, New York, 2Acibadem University School of Medicine, Istanbul, Turkey, 3NYU School of Medicine, New York, New York P-002 United States Claims Database Analysis Comparing Safety, Medical Resource Utilization, and Treatment Costs Associated with Management of Inflammatory Bowel Disease Long Gráinne1, Tatro Amanda2; Oh Young2, Reddy Sheila3, Ananthakrishnan Ashwin4 1Roche Pharmaceuticals Ltd., Welwyn Garden City, United Kingdom, 2Genentech, Inc., South San Francisco, California, 3Partnership for Health Analytic Research, Beverly Hills, California, 4Massachusetts General Hospital, Boston, Massachusetts P-003 Improved Quality of Care for IBD Patients Using HealthPROMISE App: A Randomized, Control Trial Atreja Ashish1, Khan Sameer2, Szigethy Eva3, Otobo Emamuzo4, Shroff Hersh4, Chang Helena4, Keefer Laurie5, Rogers Jason2, Deorocki Allyssa4, Ullman Thomas6, Marion James4, Cohen Benjamin4, Maser Elana7, Chapman Mark4, Itzkowitz Steven4, Colombel Jean-Frederic8, Sands Bruce2 1Mount Sinai School of Medicine, New York, New York, 2Icahn School of Medicine at Mount Sinai, New York, New York, 3Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, 4Icahn School of Medicine at Mount Sinai, New York, New York, 5Mount Sinai Health System, New York City, New York, 6Icahn School of Medicine at Mount Sinai, New York, New York, 7Mount Sinai, New York, New York, 8Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York P-004 The Use of Alvimopan as Prophylaxis against Post-Operative Ileus After Bowel Resection in Patients With Inflammatory Bowel Disease Jang Janice1, Kwok Benjamin1, Grucela Alexis1, Bernstein Mitchell1, Remzi Feza1, Hudesman David2, Chen Jingjing1, Chang Shannon1 1NYU School of Medicine, New York, New York, 2New York University School of Medicine, New York, New York P-005 Cytomegalovirus Infection in Inflammatory Bowel Diseases in a Large Single Center Cohort Toruner Murat1, Manti Bengu2, Keskin Onur2 1Ankara University School of Medicine, Ankara, Turkey, 2Ankara University School of Medicine, Ankara, Turkey

P-006

Psychiatric Characterization of Patients Enrolled in IBD Subspecialty Home

Szigethy Eva1; Weaver Emily2, Click Benjamin2, Kogan Jane3, Shrank William3, Mcauliff Katheryn4, Strassburger Meredith2, Regueiro Miguel2 1Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, 2University of Pittsburgh, Pittsburgh, Pennsylvania, 3UPMC, Pittsburgh, Pennsylvania, 4Boston College, Chestnut Hill, Massachusetts

P-007

Exposure-Response to SC Ustekinumab in Moderate –Severe Crohn’s Disease: Results From the IM-UNITI Maintenance Study

Adedokun Omoniyi1, Xu Zhenhua2, Gasink Christopher1, Jacobstein Douglas2, Szapary Philippe2, Johanns Jewel1, Gao Long-Long1, Davis Hugh3, Hanauer Stephen4, Feagan Brian5, Ghosh Subrata6, Sandborn William7 1Janssen Research and Development, LLC, Spring House, Pennsylvania, 2Janssen Research & Development, LLC, Spring House, Pennsylvania, 3Janssen Research & Development, LLC, Spring House, Pennsylvania, 4Northwestern University, Chicago, Illinois, 5Robarts Research Institute, University of Western Ontario, London, Canada, 6University of Birmingham, Birmingham, United Kingdom, 7University of California, San Diego, La Jolla, California

P-008

Relationship Between Vedolizumab Concentrations and Deep Remission in Patients With Moderately-to-Severely Active Ulcerative Colitis: A GEMINI 1 Post Hoc Analysis

Sandborn William1, Colombel Jean-Frederic2, Panaccione Remo3, Dulai Parambir4, Rosario Maria5, Cao Charlie6, Barocas Morris7, Lasch Karen8 1University of California, San Diego, La Jolla, California, 2Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, 3University of Calgary, Division of Gastroenterology, Calgary, Canada, 4University of California San Diego, LaJolla, California, 5Takeda Pharmaceuticals, Cambridge, Massachusetts, 6Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 7Takeda Pharmaceuticals U.S.A., Inc., Deerfield, Illinois, 8Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois

P-009

Response and Remission After 16 Weeks of Ustekinumab– An All Patients Analysis From the UNITI Crohn’s Studies

Colombel Jean-Frederic1, Sloan Sheldon2, Gasink Christopher3, Gao Long-Long3, Jacobstein Douglas4, Lee Scott5, Targan Stephan6 1Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, 2Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, 3Janssen Research and Development, LLC, Spring House, Pennsylvania, 4Janssen Research & Development, LLC, Spring House, Pennsylvania, 5University of Washington School of Medicine, Seattle, Washington, 6Cedars Sinai Medical Center, Los Angeles, California

P-010 Endoscopic and Clinical Efficacy Demonstrated with Oral Ozanimod in Active Crohn’s Disease in Biologic-Naïve and Biologic Experienced Patients Feagan Brian1, Sandborn William2, Danese Silvio3, D’Haens Geert4, Levesque Barrett5, Skolnick Brett5, Paul David5, Aranda Richard5, Olson Allan5 1Robarts Research Institute, University of Western Ontario, London, Canada, 2University of California, San Diego, La Jolla, California, 3Humanitas Clinical and Research Center, Milan, Italy, 4Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands, 5Receptos, a wholly owned subsidiary of Celgene, San Diego, California P-011 Etrolizumab as Induction Therapy in Moderate to Severe Crohn’s Disease: Results From BERGAMOT Cohort 1 Sandborn William1, Panes Julian2, Jones Jennifer3, Hassanali Azra4, Jacob Rhian5, Sharafali Zaineb4, Oh Young4, Tole Swati4 1University of California, San Diego, La Jolla, California, 2University of Barcelona, Barcelona, Spain, 3Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Canada, 4Genentech, Inc., South San Francisco, California, 5Roche Products Limited, Welwyn Garden City, United Kingdom P-012 Ozanimod, an Oral S1P Receptor Modulator, Is Effective and Well-Tolerated in the Long-Term Treatment of Moderate to Severe Ulcerative Colitis Feagan Brian1, Sandborn William2, D’Haens Geert3, Hanauer Stephen4, Wolf Douglas5, Vermeire Severine6, Paul David7, Petersen AnnKatrin7, Liu Jerry7, Aranda Richard7, Olson Allan7 1Robarts Research Institute, University of Western Ontario, London, Canada, 2University of California, San Diego, La Jolla, California, 3Academic Medical Centre of the University of Amsterdam, Amsterdam, The Netherlands, 4Northwestern University, Chicago, Illinois, 5Atlanta Gastroenterology Associates, Atlanta, Georgia, 6UZ Leuven Department of Gastroenterology, Leuven, Belgium, 7Receptos, a wholly owned subsidiary of Celgene, San Diego, California P-013 Pregnancy Outcomes in Women Exposed to Ustekinumab in the Crohn’s Disease Clinical Development Program Scherl Ellen1, Jacobstein Douglas2, Murphy Conor2, Ott Elyssa3, Gasink Christopher4, Baumgart Daniel5, Abraham Bincy6 1Jill Roberts IBD Center, Weill-Cornell, New York, New York, 2Janssen Research & Development, LLC, Spring House, Pennsylvania, 3Janssen Scientific Affairs, LLC, Spring House, Pennsylvania, 4Janssen Research and Development, LLC, Spring House, Pennsylvania, 5Charite University, Berlin, Germany, 6Houston Methodist, Houston, Texas

P-014

Ustekinumab IV Induction Results in Crohn’s Disease Symptom Improvement Within the First Week in Anti-TNF Refractory Patients

Sandborn William1, Yeager Benjamin2, Gasink Christopher3, Hoops Timothy2, Gao Long-Long3, Wang Yanli4, Jacobstein Douglas4, Lee Scott5, Hanauer Stephen6 1University of California, San Diego, La Jolla, California, 2Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, 3Janssen Research and Development, LLC, Spring House, Pennsylvania, 4Janssen Research & Development, LLC, Spring House, Pennsylvania, 5University of Washington School of Medicine, Seattle, Washington, 6Northwestern University, Chicago, Illinois

P-015

Maintenance of Remission with Tofacitinib in Patients With Ulcerative Colitis: Subpopulation Analysis from an Open-Label, Long-Term Extension Study

Colombel Jean-Frederic1, Reinisch Walter2, Osterman Mark T3, Thorpe Andrew J4, Nduaka Chudy I4, Zhang Haiying4, Lawendy Nervin4, Friedman Gary S4, Su Chinyu5 1Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, 2Medical University of Vienna, Dept Internal Medicine III, Vienna, Austria, 3Penn Presbyterian Medical Center, Division of Gastroenterology, Philadelphia, Pennsylvania, 4Pfizer Inc, Collegeville, Pennsylvania, 5Pfizer Inc, Collegeville, Pennsylvania

P-016 YI

Complications After Colonoscopy in Patients With Inflammatory Bowel Disease

Wang Peiqi1, Ngamruengphong Saowanee2, Selaru Florin2, Parian Alyssa3, Melia Joanna4, Lazarev Mark4, Hutfless Susan5 1The Johns Hopkins University, Baltimore, Maryland, 2Johns Hopkins University, Baltimore, Maryland, 3Johns Hopkins University, Baltimore, Maryland, 4Johns Hopkins University School of Medicine, Baltimore, Maryland, 5Division of Gastroenterology, Department of Medicine, Johns Hopkins University Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

P-017

Advanced Age is Associated with Decreased Long Term Functional Outcomes Following Ileal Pouch Anal Anastomosis

McKenna Nicholas, Mathis Kellie, Pemberton John, Lightner Amy Mayo Clinic Rochester, Rochester, Minnesota

P-018

Transabdominal Pouch Salvage for Failed Laparoscopic Ileal Pouch-Anal Anastomosis

Aydinli H. Hande1, Aytac Erman2, Ashburn Jean3, Kessler Hermann4, Remzi Feza5 1NYU Langone Medical Center, New York, New York, 2Acibadem University School of Medicine, Istanbul, Turkey, 3Cleveland Clinic, Cleveland, Ohio, 4Cleveland Clinic, Cleveland, Ohio, 5NYU School of Medicine, New York, New York

P-019

Ustekinumab IV 6 mg/kg Loading Dose Re-induction Improves Clinical and Endoscopic Response in Crohn’s Disease: A Case Series

Park Sunhee1, Evans Elisabeth2, Sandborn William3, Boland Brigid4 1UC Irvine, San Diego, California, 2Inflammatory Bowel Disease Center, Division of Gastroenterology, UC San Diego Health System, La Jolla, California, 3University of California, San Diego, La Jolla, California, 4UCSD, La Jolla, California

P-020

Therapeutic Effect of Vancomycin in UC Patients Associated With PSC: Case Series

Lodhi Fahad, Mankongpaisarnrung Charoen, Gerber Daniel; Charabaty Aline Georgetown University Hospital, Washington, District of Columbia

P-021 YI

Common Variable Immunodeficiency Masquerading as Ulcerative Colitis

Cooley David1, Liggett Michael2, Gamarra Roberto1 1Providence-Providence Park Hospital/Michigan State University of Human Medicine, Southfield, Michigan, 2Cincinnati State, Cincinnati, Ohio

P-022 YI

Novel Therapy for Collagenous Colitis - A Case Report

Sharp Melissa1, White Betty2 1Loma Linda University, Tacoma, Washington, 2Digestive Health Specialists, Tacoma, Washington

P-023

Vedolizumab for the Treatment of Refractory Microscopic Colitis

Samuel Gbeminiyi1, LeStrange Aimee2, Charabaty Aline2 1Howard University Hospital, Washington, District of Columbia, 2Georgetown University Hospital, Washington, District of Columbia

P-024

Four Cases of Reoperative Pouch Surgery After Failed Minimally Invasive Pouch Creation

Aydinli H. Hande1, Schwartzberg David1, Remzi Feza2 1NYU Langone Medical Center, New York, New York, 2NYU School of Medicine, New York, New York

P-025 YI

Metastatic Crohn's Disease of the Vulva: A Diagnostic Challenge

Al-Chalabi Ahmed, Sodeman Thomas, Lay Roberta, Nawras Ali University of Toledo Medical Center, Toledo, Ohio

P-026

Prepouch Ileitis - Does It Really Exist Or Is It a Misdiagnosis of Crohn’s Disease?

Hakim Seifeldin, Amin Mitual, Cappell Mitchell William Beaumont Hospital, Royal Oak, Michigan

P-027 YI

A Rare Case of Crohn’s Disease-Associated Aortitis

Hughes Michelle1; Sahay Tanya1, Saubermann Lawrence2 1University of Rochester Medical Center, Rochester, New York, 2University Of Rochester- Division of Gastroenterology and Hepatology, Rochester, New York

P-028

Early Pouchoscopy Is Not Helpful for Surveillance of Dysplasia in the Ileal Pouch

Torres Esther1, Lojo Juan2; Feliciano Gisela3, Gonzalez Carmen2 1UPR Medical Science Campus, San Juan, Puerto Rico, 2University of Puerto Rico School of Medicine, San Juan, Puerto Rico, 3Ponce School of Medicine, Ponce, Puerto Rico

P-029

Patient Characteristics and Clinical Outcomes in Biologic-Naïve Patients With Crohn’s Disease Initiating Vedolizumab Treatment Early Versus Later After Diagnosis

Patel Haridarshan1, Raluy-Callado Mireia2, Berger Ariel3, Donaldson Robert4, Bhurke Sharvari3, Khalid Javaria Mona5 1Immensity Consulting, Chicago, Illinois, 2Evidera, London, United Kingdom, 3Evidera, Waltham, Massachusetts, 4Evidera, London, United Kingdom, 5Takeda Development Centre Europe, Ltd., London, United Kingdom

P-031 Ustekinumab Provides Steroid-Sparing and Perianal Improvement in IBD Patients: Single Center Experience Krugliak Cleveland Noa1, Normatov Inessa1, Buisson Anthony2, Glick Laura1, Zmeter Nada1, El Jurdi Katia1, Yvellez Olivia1, Pekow Joel3, Cohen Russell D.3, Rubin David T.4 1University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 2 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 3University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 4University of Chicago Medicine, Chicago, Illinois P-032 Beliefs About Medications in IBD Jelsness-Jørgensen Lars-Petter1, Bernklev Tomm2 1Østfold University College, Halden, Norway, 2Vestfold Hospital Trust, Skien, Norway P-033 Enteric Infections Among IBD Patients: Results From the Nationwide Emergency Department Sample, 2010-2012 Love Bryan University of South Carolina, Columbia, South Carolina P-034 Prevalence of Crohn’s Disease and Ulcerative Colitis in Colombia: Analysis of the Integral Information System of Social Protection (Sispro) Juliao Fabian1, Calixto Omar2 1Pablo Tobón Uribe Hospital, Medellín, Columbia, 2Janssen Pharmaceutical Colombia, Bogotá, Columbia P-035 YI Inflammatory Bowel Disease Training During Adult Gastroenterology Fellowship: A National Survey of Canadian Program Directors and Trainees Gallinger Zane1, Rumman Amir2, Alghamdi Sarah3, Pivovarov Kevin3, Dubinsky Marla4, Nguyen Geoffrey5, Cohen Benjamin6 1The Mount Sinai Hospital, New York, New York, 2University of Toronto, Toronto, Canada, 3University of Toronto, Toronto, Canada, 4Cedars Sinai Medical Center, Los Angeles, California, 5Mt Sinai Hospital IBD Centre, University of Toronto, Toronto, Canada, 6Icahn School of Medicine at Mount Sinai, New York, New York

P-036 High-Dosed Intravenous Iron Replacement Therapy for Iron Deficiency Anemia Does Not Hinder Drug-Induced Amelioration of Disease Activity in IBD Patients Stein Jürgen1, Vollmer Stefan2, Klemm Wolfgang3, Nip Kerry4, Weber-Mangal Susanne4, Dignass Axel5 1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Gastroenterological Practice, Goeppingen, Germany, 3Gastroenterological Practice, Cottbus, Germany, 4Vifor Pharma, Munich, Germany, 5Agaplesion Markus Krankenhaus, Frankfurt, Germany P-037 Mucosal Gene Transcript of Tumor Necrosis Factor in Personalized Medicine of Inflammatory Bowel Disease Goll Rasmus1, Meyer Renate2, Moe Øystein3, Knut Johnsen3, Gundersen Mona1, Florholmen Jon1 1University of Tromsoe - The Arctic University of Norway, Tromsoe, Norway, 2University Hospital of North Norway, Tromsø, Norway, 3Finnmarkssykehuset, Hammerfest, Norway P-038 Vaccinate the Veterans! Immunization Rates in Veterans With Inflammatory Bowel Disease at the James A. Haley Veterans Hospital Vellanki Meghana1; Rosario Michelle1, Bromberg David1, Slone Samuel1, Narayanan Shreya1, Foulis Philip2, Chae Soojong1, Laffer Dennis3, Goldsmith Susan4 1University of South Florida, Tampa, Florida, 2University of South Florida, James A. Haley Veterans Affairs, Tampa, Florida, 3James A. Haley Veterans Affairs, Tampa, Florida, 4James A Haley VA, Tampa, Florida P-039 Factors Influencing Length of Hospital Stay and Hospital Charges in Patients With Inflammatory Bowel Disease: A Five-Year Population Based Study Eke Ransome1; Tariq Tooba1, Bystrom Philip1, Chen Andrew2 1Western Michigan University School of Medicine, Kalamazoo, Michigan, 2Western Michigan University School of Medicine, Portage, Michigan P-040 Do Nurses and Physicians Know How Much Pain and Anxiety Their IBD Inpatients Have? Weisshof Roni1, Labas Jennifer2, Hirsch Ayal2, Aharoni Golan Maya3, Conroy Meghan K.4, Micic Dejan2, Rubin David T.5 1University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 2University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 3University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 4 University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 5University of Chicago Medicine, Chicago, IL

P-041 Analysis of Hospital Discharges and Deaths From Nationwide Health Registry of Inflammatory Bowel Disease in Mexico From 2004 to 2015 Sarmiento Andrea1, Ríos María2, Toledo Joel1, Yamamoto Jesús1 1National Institute of Medical Science and Nutrition Salvador Zubirán, Mexico City, Mexico, 2National Institute of Public Health, Cuernavaca, Mexico P-042 Predictors of Severity in Inflammatory Bowel Diseases Farinelli Elen1, da Silva Rosemary1, Síbia Carina1, Renosto Fernanda1, de Barros Jaqueline1; Baima Julio2, Saad-Hossne Rogerio3, Sassaki Ligia4 1Faculty of Medicine of Botucatu, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Botucatu, Brazil, 3Digestive Surgery Department, Unesp Botucatu, Botucatu, Brazil, 4Unesp- FMB, Botucatu, Brazil P-043 The Economic Burden Associated With Inflammatory Bowel Disease Severity Raimundo Karina1, Montagut Teresa1, Flores Natalia2 1Genetech, Inc., South San Francisco, California, 2Kantar Health, San Mateo, California P-044 Clinical and Sociodemographic Characteristics of Inflammatory Bowel Disease in Mexico: A Multi-center and Nationwide Study (EPIMEX-IBD) Sarmiento Andrea1, Toledo Joel1, Bozada Katya1, Valenzuela Jesús2, Jaramillo Christian3, Angulo Felipe4, Casanova Azucena5, Bermúdez Emilio6, Yamamoto Jesús1 1National Institute of Medical Science and Nutrition Salvador Zubirán, Mexico City, Mexico, 2Hospital Civil de Guadalajara Dr. Juan I. Menchaca, Guadalajara, Mexico, 3Hospital General Regional 110 IMSS, Guadalajara, Mexico, 4Hospital Regional de Alta Especialidad de la Península de Yucatán, Mérida, Mexico, 5Hospital General de México Dr. Eduardo Liceaga, Mexico City, Mexico, 6Hospital General de Zona 25 IMSS, Mexico City, Mexico P-045 Visceral Fat Is Increased in Individuals With Crohn’s Disease: A Comparative Analysis With Healthy Controls Magro Daniela1, Barreto Maria Rita2, Cazzo Everton3, Machado Julia3, Martinez Carlos Augusto4, Camargo Michel5, Ayrizono Maria de Lourdes3, Kotze Paulo6, Coy Claudio7 1University of Campinas, Campinas, Brazil, 2Unicamp - Campinas - SP - Brazil, Campinas, Brazil, 3Unicamp, Campinas, Brazil, 4Campinas State University, Santo Andre, Brazil, 5Unicamp - Campinas - SP - Brazil, Campinas, Brazil, 6Colorectal Surgery Unit - Cajuru University Hospital - Catholic University of Parana, Curitiba, Brazil, 7Unicamp, Campinas, Brazil

P-046 Healthcare Costs Associated With Oral Versus Intravenous Iron Therapy in IBD Patients With Anemia Or Non-anemic Iron Deficiency in Germany Stein Jürgen1, Haas Jennifer2, Ong Siew-Hwa3, Borchert Kathrin2, Hardt Thomas4, Lechat Elmira3, Nip Kerry5, Foerster Douglas3, Braun Sebastian2, Baumgart Daniel6 1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Xcenda GmbH, Hannover, Germany, 3Vifor Pharma Ltd, Glattbrugg, Switzerland, 4Vifor Pharma Deutschland GmbH, Munich, Germany, 5Vifor Pharma, Munich, Germany, 6Charite University, Berlin, Germany P-047 The Incidence and Risk Factors of Venous Thromboembolism in Japanese Inpatients With Inflammatory Bowel Disease: A Retrospective and Prospective Study Ando Katsuyoshi1, Fujiya Mikihiro1, Nomura Yoshiki1, Ueno Nobuhiro1, Inaba Yuhei2, Sugiyama Yuya1, Iwama Takuya1, Ijiri Masami1, Takahashi Keitaro1, Tanaka Kazuyuki1, Goto Takuma1, Kashima Shin1, Sasajima Junpei1, Moriichi Kentaro1, Mizukami Yusuke1, Yamada Satoshi3, Nakase Hiroshi4, Okumura Toshikatsu1 1Asahikawa Medical University, Asahikawa, Japan, 2Asahikawa City Hospital, Asahikawa, Japan, 3Kyoto University, Graduate School of Medicine, Kyoto, Japan, 4Sapporo Medical University, School of Medicine, Sapporo, Japan P-048 YI Antibiotic and Steroid Use - Risk Factors for Gut Colonization With ESBL Producing Enterobacteria In Ulcerative Colitis Out-Patients Skuja Vita1, Pekarska Katrina1, Dauvarte Helena2, Vasuka Elina3, Dobelniece Lauma2, Malina Justine2, Rudzite Dace4, Kalcenaua Agate3, Oscepkova Anastasija3, Krumina Angelika4, Lejnieks Aivars4, Derovs Aleksejs4 1Riga Stradins University, Riga, Latvia, 2Riga Stradins University, Riga, Latvia, 3Riga Stradins Univerity, Riga, Latvia, 4Riga East Clinical University Hospital, Riga, Latvia P-049 Using an Inflammatory Bowel Disease Objective Structured Clinical Examination to Assess ACGME Milestones in Gastroenterology Fellows Zalkin Dana1, Malter Lisa2, Balzora Sophie1, Weinshel Elizabeth3, Zabar Sondra4, Gillespie Colleen3 1NYU, New York, New York, 2NYU School of Medicine, New York, New York, 3New York University School of Medicine, New York, New York, 4New York University School of Medicine, New York, New York P-050 Novel Regulatory DNA Methylation Features of Relevance for Ulcerative Colitis Paulssen Ruth, Taman Hagar, Fenton Christopher, Hensel Inga, Anderssen Endre, Florholmen Jon University of Tromsoe - The Arctic University of Norway, Tromsoe, Norway

P-051 Analyzing the Safety Profiles of IBD Biologics Jow Steven1, Hutfless Susan2 1Saba University School of Medicine, Devens, Massachusetts, 2Division of Gastroenterology, Department of Medicine, Johns Hopkins University Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland P-052 The Influence of Extraintestinal Manifestations on Outcomes of Ulcerative Colitis Patients Undergoing Colectomy Yuquimpo Kyle, Pourghaderi Poya, Lacy Sean, Wright Barth Kansas City University of Medicine and Biosciences, Kansas City, Missouri P-053 YI Evaluation of Crohn's Disease Activity in Pregnant Women: A Tertiary Center Experience Santos Ana, Lopes Susana, Silva Marco, Peixoto Armando, Moreira Pedro, Macedo Guilherme Centro Hospitalar de São João, Porto, Portugal P-054 Ferric Carboxymaltose Therapy in IBD Patients With Iron Deficient Anemia: Real-Life Data From Germany Stein Jürgen1, Vollmer Stefan2, Klemm Wolfgang3, Nip Kerry4, Weber-Mangal Susanne4, Dignass Axel5 1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Gastroenterological Practice, Goeppingen, Germany, 3Gastroenterological Practice, Cottbus, Germany, 4Vifor Pharma, Munich, Germany, 5Agaplesion Markus Krankenhaus, Frankfurt, Frankfurt/Main, Germany P-055 YI The Prevalence of Sarcopenia and Its Effect on Prognosis in Patients With Crohn’s Disease Oh Dong Jun1, Yoon Hyuk2, Lee Jae Min1, Choi Yoon Jin3, Shin Cheol Min3, Park Young Soo3, Kim Nayoung3, Lee Dong Ho3 1Department of Internal Medicine and Seoul National University Bundang Hospital, Seongnam-si, South Korea, 2Seoul National University College of Medicine, Seoul, South Korea, Seongnam-si, South Korea, 3Seoul National University College of Medicine, Seoul, South Korea, Seongnam-si, South Korea P-056 Gender Differences in Stoma-Related Quality of Life in Puerto Ricans With IBD Lojo Juan1, De la Villa Ricardo2, Vega Mayte2, Torres Esther3 1University of Puerto Rico School of Medicine, San Juan, Puerto Rico, 2University of Puerto Rico, San Juan, Puerto Rico, 3UPR Medical Science Campus, San Juan, Puerto Rico

P-057 YI

Frequency of Extraintestinal Manifestations in Patients With Inflammatory Bowel Diseases in Moscow City

Kagramanova Anna, Knyazev Oleg, Lishchinskaya Albina, Fadeeva Nina, Dobrolyubova Ekaterina, Donchenko Irina, Parfenov Asfold Moscow Clinical Research Centre, Moscow City, Russia

P-058

National Trends of Endoscopies Performed in Inflammatory Bowel Disease Patients From 2008 to 2012

Htun Zin Mar1, Gul Muhammad2, Kyaw May3, Shaukat Nauman4, Imran Muhammad5, Lin Kyawzaw6, Aye Htar Htar7, Lwin Aung Khine8 1Louis A. Weiss Memorial Hospital, Chicago, Illinois, 2Presence St. Joseph Hospital, Chicago, Illinois, 3Long Island Jewish Forest Hills Hospital, New York, New York, 4Saint Louis University, St. Louis, Missouri, 5Civil Military Hospital, Rawalpindi, Pakistan, 6The Brooklyn Hospital Center, Brooklyn, New York, 7Fayetteville VA Medical Center, Fayetteville, North Carolina, 8University of Medicine 1, Yangon, Myanmar

P-059 YI

Frequency of Small Intestinal Bacterial Overgrowth (SIBO) in Patients With Ulcerative Colitis Using Hydrogen and Methane-Based Breath Tests With Lactulose

Adame Enrique1, Escobar Salvador1; Olivares Laura2 1National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico, 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico, Mexico

P-060 YI

Correlation of Fecal Calprotectin With Acute Phase Reactants (ESR, CRP) in Mexican Patients With Ulcerative Colitis

Yamamoto Jesús1; Olivares Laura2 1National Institute of Medical Science and Nutrition Salvador Zubirán, Mexico City, Mexico, 2instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Ciudad de Mexico , Mexico

P-061

History of Clostridium Difficile Infection Is Not Associated With Microscopic Colitis

Redd Walker1; Hunold Thomas1, Hays Rachel2 1University of Virginia, Charlottesville, Virginia, 2UVA Health System, Charlottesville, Virginia

P-062 Simplified Daily Assessments of Sleep Quality, Pain and Quality of Life in IBD Patients Correlate with Validated Measures Andersen Jr. Michael1, Lei Donald2, Aharoni Golan Maya3, Yvellez Olivia1, Rodriquez Dylan4, Zmeter Nada1, Rubin David T.5 1University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois , 2University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 3University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, 4University of Chicago Inflammatory Bowel Disease Center, Chicago, Illinois, 5University of Chicago Medicine, Chicago, Illinois P-063 A Retrospective Evaluation of the Quality of Referrals to IBD Specialist Care and Its Influence on Patient Outcomes Mathias Holly1, Heisler Courtney1, Morrison Julia2, Jones Jennifer1 1QEII Health Sciences Centre, Halifax, Canada, 2Nova Scotia Health Authority, Halifax, Canada P-064 Frequency of Micronutrient Deficiencies in Mexican Patients With Inflammatory Bowel Disease Sarmiento Andrea, Parra Norma, Ávila José, Gómez Eduardo, Lara Karen, Yamamoto Jesús National Institute of Medical Science and Nutrition Salvador Zubirán, Mexico City, Mexico P-065 YI Gut Colonization With ESBL Producing Enterobacteria May Worsen the Health Related Quality of Life in Ulcerative Colitis Out-Patients Skuja Vita1, Pekarska Katrina1, Dauvarte Helena2, Vasuka Elina3, Dobelniece Lauma2, Malina Justine2, Rudzite Dace4, Kalcenaua Agate3, Oscepkova Anastasija3, Krumina Angelika4, Lejnieks Aivars4, Derovs Aleksejs4 1Riga Stradins University, Riga, Latvia, 2Riga Stradins University, Riga, Latvia, 3Riga Stradins University, Riga, Latvia, 4Riga East Clinical University Hospital, Riga, Latvia P-066 Primary Sclerosing Cholangitis Is Associated With Ileocolonic CD and Extensive UC in Patients From Northeast of Brazil Silva Juliana1, Brito Beatriz1, Fortes Flora Maria2, Pimentel Andréa2, Fontes Jaciane2, Almeida Neogélia2, Surlo Valdiana2, Novais Hemmerson3, Neri Isaac4, Liberato Renata5; Santana Genoile1 1Universidade do Estado da Bahia, Salvador, Brazil, 2Hospital Geral Roberto Santos, Salvador, Brazil, 3Universidade do Estado da Bahia, Salvador, Brazil, 4Universidade do Estado da Bahia, Salvador, Brazil, 5Universidade Federal da Bahia, Salvador, Brazil

P-067 Prevalence of Contraindications/Precautions to Tumor Necrosis Factor Alpha Blockers Among Patients With Inflammatory Bowel Disease in the United States Bhurke Sharvari1, Do Thy2, Donaldson Robert3, Berger Ariel1, Bojic Daniela2, Khalid Javaria Mona4; Patel Haridarshan5 1Evidera, Waltham, Massachusetts, 2Takeda, Zurich, Switzerland, 3Evidera, London, United Kingdom, 4Takeda Development Centre Europe, Ltd., London, United Kingdom, 5Immensity Consulting, Chicago, Illinois P-068 The Expression of MicroRNAs in IBD Saad-Hossne Rogerio1, Sassaki Ligia2, Síbia Carina3, Reis Patricia4, Baima Julio5 1Digestive Surgery Department, Unesp Botucatu, Botucatu, Brazil, 2UNESP/FMB, Botucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4Paulista State University, Botucatu, Brazil, 5Faculty of Medicine of Botucatu, Botucatu, Brazil P-069 Prevalence of Depression in Patients With Inflammatory Bowel Disease from the Gastroenterologist Service at National Medical Center 20 de Noviembre Rivera Vicencio Yahaira1, López Goméz Jesús2, Rodriguez Romo Roxana1, Cortes Espinosa Tomas2, Ramos Gómez Mayra3 1National Medical Center 20 de Noviembre, Mexico City, Mexico, 2National Medical Center “20 de Noviembre” ISSSTE, Mexico, Mexico, 3National Medical Center “20 de Noviembre” ISSSTE, Mexico, Mexico P-070 Generating an IBD-Specific Patient-Centric Symptom Score Obremskey Alexandra1, Hwang Caroline2, Doctor Jason3, van den Akker-van Marle Elske4, van Deen Welmoed5 1Keck School of Medicine of USC, Santa Monica, California, 2Keck Medical Center at USC, Los Angeles, California, 3USC Schaeffer Center for Health Policy & Economics, Los Angeles, California, 4Leiden University Medical Center Department of Medical Decision Making, Leiden, The Netherlands, 5USC Gehr Family Center for Health Systems Science, Los Angeles, California P-071 Patient Wait Time Recall Accuracy for Gastroenterology Specialty Consultation in Nova Scotia Heisler Courtney, Mathias Holly, Jones Jennifer QEII Health Sciences Centre, Halifax, Canada

P-072 YI

Body Mass Index and Activity Index in Ulcerative Colitis and Crohn's Disease, an Established Association?

Pineda Castillejos Jorge1, López Goméz Jesús2, Rivera Vicencio Yahaira3, Rodriguez Romo Roxana3, Cortes Espinosa Tomas2, Ramos Gómez Mayra4 1National Medical Center "20 de Noviembre", Mexico, Mexico, 2National Medical Center “20 de Noviembre” ISSSTE, Mexico, Mexico, 3National Medical Center 20 de Noviembre, Mexico City, Mexico, 4National Medical Center “20 de Noviembre” ISSSTE, Mexico, Mexico

P-074 YI

Combined Anticytokine and Local Mesenchymal Stromal Cells Therapy Promotes Longer Healing of Simple Fistulas in Patients With Crohn's Disease

Kagramanova Anna1, Knyazev Oleg2, Dobrolyubova Ekaterina3, Lishchinskaya Albina4, Belyakov Nikita3, Orlova Natalya5, Boldyreva Oxana3, Konoplyannikov Anatoliy6, Parfenov Asfold2 1Moscow Clinical Research Centre, Moscow City, Russia, 2Moscow Clinical Research Centre, Moscow, Russia, 3Moscow Clinical Research Center, Moscow, Russia, 4Moscow Clinical Research Centre, Moscow City, Russia, 5Moscow Clinical Research Center, Moscow, Russia, 6Medical Radiological Research Center, Obninsk, Russia

P-075

Combined Stem Cells and Anticytokine Therapy Contributes Decrease in the Degree of Inflammation of the Intestinal Mucosa in Crohn's Disease

Knyazev Oleg1; Fadeeva Nina2, Khomeriki Sergey3, Kagramanova Anna4, Konoplyannikov Anatoliy5, Lishchinskaya Albina2, Donchenko Irina3, Parfenov Asfold1 1Moscow Clinical Research Centre, Moscow, Russia, 2Moscow Clinical Research Centre, Moscow City, Russia, 3Moscow Clinical Research Center, Moscow, Russia, 4Moscow Clinical Research Centre, Moscow City, Russia, 5Medical Radiological Research Center, Obninsk, Russia

P-076 YI

Dynamics of Proinflammatory Cytokines in Patients With Crohn's Disease Who Received Combined Therapy With Mesenchymal Stromal Cells and Azathioprine

Knyazev Oleg1; Kagramanova Anna2, Fadeeva Nina3, Dobrolyubova Ekaterina4, Noscova Karina4, Konoplyannikov Anatoliy5, Lishchinskaya Albina3, Parfenov Asfold1 1Moscow Clinical Research Centre, Moscow, Russia, 2Moscow Clinical Research Centre, Moscow City, Russia, 3Moscow Clinical Research Centre, Moscow City, Russia, 4Moscow Clinical Research Center, Moscow, Russia, 5Medical Radiological Research Center, Obninsk, Russia

P-077 YI

Comparative Relapse Rate in Patients With Inflammatory Bowel Diseases Receiving Mesenchymal Stromal Cells - 5 Years Of Follow-Up

Knyazev Oleg1; Fadeeva Nina2, Lishchinskaya Albina2, Konoplyannikov Anatoliy3, Kagramanova Anna4, Dobrolyubova Ekaterina5, Donchenko Irina5, Ruchkina Irina6, Boldyreva Oxana5, Parfenov Asfold1 1Moscow Clinical Research Centre, Moscow, Russia, 2Moscow Clinical Research Centre, Moscow City, Russia, 3Medical Radiological Research Center, Obninsk, Russia, 4Moscow Clinical Research Centre, Moscow City, Russia, 5Moscow Clinical Research Center, Moscow, Russia, 6Central Research Institute of Gastroenterology, Moscow, Russia

P-078

Quality of Life, Anxiety, Depression and Sexual Dysfunction in Patients With Chronic Intestinal Diseases

Andriolli Guilherme1; Baima Julio2, Yao Tiago1, de Barros Jaqueline3, Saad-Hossne Rogerio4, Sassaki Ligia5 1UNESP, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Botucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4Digestive Surgery Department, Unesp Botucatu, Botucatu, Brazil, 5Unesp- FMB, Botucatu, Brazil

P-079 YI

Effect of Multi-modal Educational Interventions to Improve Healthcare Maintenance of IBD Patients in an Urban Medical Center

Ni Katherine; Rolston Vineet, Dikman Andrew, Liang Peter, Malter Lisa New York University School of Medicine, New York City, New York

P-080

Steroids Use Is the Major Factor Associated With Clostridium Difficile Infection During IBD Flares in the Outpatient Setting

Garcia Patrícia1; Chebli Liliana2, Ribeiro Tarsila3, Castro Antônio Carlos4, Gaburri Pedro3, Pace Fábio3, Barbosa Kátia3, Costa Lívia1, Raimundo Roberta1, Moraes Bernardo1, Assis Isabelle1, Zanini Alexandre1, Chebli Julio5 1UFJF, Juiz de Fora, Brazil, 2Federal University of Juiz de Fora, Juiz de Fora, Brazil, 3Federal University of Juiz de Fora, Juiz de Fora, Brazil, 4Federal University of Viçosa, Juiz de Fora, Brazil, 5Inflammatory Bowel Diseases Center, Federal University of Juiz de Fora, Juiz de Fora, Brazil

P-081

Body Fluids Composition Estimated by Bioelectrical Impedance in Patients With Inflammatory Bowel Diseases

Batista Gabriela1, Dorna Mariana2; Baima Julio3, de Barros Jaqueline4, Gondo Fernanda5, Biondi Robertha4, Sassaki Ligia6, Rupp de Paiva Sergio Alberto7 1UNESP, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Boucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4Faculty of Medicine of Botucatu, Botucatu, Brazil, 5 Institute of Biosciences, UNESP / Botucatu., Botucatu, Brazil, 6Unesp- FMB , Botucatu, Brazil, 7Botucatu Medical School, São Paulo State University/UNESP, Botucatu, Brazil

P-082

Rates of Clinical Response, Clinical Remission and Endoscopic Response in Crohn's Disease: Monotherapy Versus Combined Therapy

Moutinho Bruna1; Baima Julio2, Saad-Hossne Rogerio3, Sassaki Ligia4 1UNESP, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Botucatu, Brazil, 3Digestive Surgery Department, Unesp Botucatu, Botucatu, Brazil, 4Unesp- FMB , Botucatu, Brazil

P-083 YI

Internists’ Vs. Gastroenterologists’ Practice and Perception of Responsibility of IBD-Related Health Maintenance

Hammami Muhammad, Pandit Pratik, Talkin Rebecca, Schroeder Katie Saint Louis University, Saint Louis, Missouri

P-084

Safety of Short 30 Minutes Infliximab Infusion: A Pilot Study

Damon Alyssa1, Mia Hodges2, Zack Jeremy1, LeStrange Aimee3, Mattar Mark4, Prins Petra5; Charabaty Aline3 1Reusch Center, Washington, District of Columbia, 2Reusch Center, Washington, District of Columbia, 3Georgetown University Hospital, Washington, District of Columbia, 4MedStar Georgetown University Hospital, Washington, District of Columbia, 5Georgetown University, Washington, District of Columbia

P-085 YI

Psychiatric Conditions Are Associated With Medical Noncompliance and Worsening Disease Course in IBD Patient Population

Lee Jai Eun, Abboud Rami, Larion Sebastian, McPhail Jim, White Bradley, Sifuentes Humberto Medical College of Georgia/Augusta University Medical Center, Augusta, Georgia

P-086 YI

Analysis of Factors Associated With Clostridium Difficile Infection Among Hospitalized Patients With Underlying Pouchitis

Kistangari Gaurav1, Gosai Falgun2, Lopez Rocio3, Shen Bo4 1University at Buffalo, Buffalo, New York, 2Fairview Hospital, Cleveland Clinic, Cleveland, Ohio, 3Cleveland Clinic Foundation, Cleveland, Ohio, 4Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio

P-087 Low Incidence of Hepatitis B Seropositivity in Inflammatory Bowel Disease Patients Prior to AntiTNF Therapy Damon Alyssa1, Mia Hodges2, Zack Jeremy1, Prins Petra3; Charabaty Aline4 1Reusch Center, Washington, District of Columbia, 2Reusch Center, Washington, District of Columbia, 3Georgetown University, Washington, District of Columbia, 4Georgetown University Hospital, Washington, District of Columbia P-088 Conventional Therapy in Adults With Moderate to Severe Inflammatory Bowel Disease: A Systematic Literature Review Feitosa Flavio1, Damião Adérson2 1Departamento Médico, Takeda Distribuidora Ltda, São Paulo, Brazil, 2Medical School, University of São Paulo, São Paulo, Brazil P-089 Cardiovascular Risk in Crohn's Disease and Ulcerative Colitis Patients Biondi Robertha1, Dorna Mariana2; Baima Julio3, da Silva Rosemary1, Batista Gabriela4, Hueb Joao4, Sassaki Ligia5, Rupp de Paiva Sergio Alberto6 1Faculty of Medicine of Botucatu, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Boucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4UNESP, Botucatu, Brazil, 5Unesp- FMB, Botucatu, Brazil, 6Botucatu Medical School, São Paulo State University/UNESP, Botucatu, Brazil P-090 YI Hypoalbuminemia as Risk Factor for Thromboembolic Events in Hospitalized Inflammatory Bowel Disease Patients: An Observational and Retrospective Analysis Imbrizi Marcello1, Lopes Tirzah1, Cunha-Silva Marlone1, Magro Daniela2, Kotze Paulo3, Montes Ciro1, Almeida Jazon1, Cabral Virgínia1 1University of Campinas, Campinas, Brazil, 2University of Campinas, Campinas, Brazil, 3Colorectal Surgery Unit - Cajuru University Hospital - Catholic University of Parana, Curitiba, Brazil P-091 Causes of Admission in IBD: How Nationwide Trends Have Changed From 2002 to 2007-2012 Htun Zin Mar1, Gul Muhammad2, Lin Kyawzaw3, Kyaw May4, Shaukat Nauman5, Aye Htar Htar6, Imran Muhammad7, Lwin Aung Khine8 1Louis A. Weiss Memorial Hospital, Chicago, Illinois , 2Presence St. Joseph Hospital, Chicago, Illinois, 3The Brooklyn Hospital Center, Brooklyn, New York, 4Long Island Jewish Forest Hills Hospital, New York, New York, 5Saint Louis University, St. Louis, Missouri, 6Fayetteville VA Medical Center, Fayetteville, North Carolina, 7Civil Military Hospital, Rawalpindi, Pakistan, 8University of Medicine 1, Yangon, Myanmar

P-092 Adherence to Quality of Care Indicators is Greater in Inflammatory Bowel Disease Dedicated Gastroenterologists Thomas Alex1, Walker Ted2, Gutierrez Alexandra3, Bruns Mark1, Hiatt-Jensen, Deborah Deborah4, Stenson William1, Deepak Parakkal1, Ciorba Matthew5, Christophi George2 1Washington University School of Medicine, Saint Louis, Missouri, 2Washington University School of Medicine, St Louis, Missouri, 3Washington University, St. Louis, Missouri, 4Washington University School of Medicine, Creve Coeur, Missouri, 5Washington University in St. Louis, Saint Louis, Missouri

P-093 Improvement of Disability in Ulcerative Colitis Patients After One Year With Anti-TNF Agents Bissoli Gabriela1, da Silva Rosemary2; Baima Julio3, Farinelli Elen2, Síbia Carina2, de Barros Jaqueline2, Biondi Robertha2, Renosto Fernanda2, Saad-Hossne Rogerio4, Sassaki Ligia5 1UNESP, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Botucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4Digestive Surgery Department, Unesp Botucatu, Botucatu, Brazil, 5Unesp- FMB, Botucatu, Brazil P-094 Crohn's Disease and Sarcopenia: Predicting Surgical Outcomes Shah Marmy1; Ray Jennifer2, Sontag Stephen1, Hayden Dana3 1Hines VA Hospital, Hines, Illinois, 2Loyola University Medical Center, Maywood, Illinois, 3Loyola University, Maywood, Illinois P-095 YI Vaccinations in IBD Patients: Internists’ Practice and Perceptions of Responsibility Hammami Muhammad, Pandit Pratik, Talkin Rebecca, Schroeder Katie Saint Louis University, Saint Louis, Missouri P-096 Physical Activity in Daily Life and Exercise Capacity in Patients With Crohn's Disease on Infliximab-Induced Remission: A Cross-Sectional Study Cabalzar Andrea1, Chebli Liliana2; Ribeiro Tarsila1, Lucca Fernando1, Gaburri Pedro1, Reboredo Maycon1, Pinheiro Bruno1, Malaguti Carla3, Chebli Julio4 1Federal University of Juiz de Fora, Juiz de Fora, Brazil, 2Federal University of Juiz de Fora, Juiz de Fora, Brazil, 3Federal University of São Carlos, Juiz de Fora, Brazil, 4Inflammatory Bowel Diseases Center, Federal University of Juiz de Fora, Juiz de Fora, Brazil

P-097 YI Corticosteroid Use Is Not Associated With Decreased Length of Stay in Patients Hospitalized With Crohn’s Associated Small Bowel Obstruction Quarta Giulio1, Thanawala Shivani1, Liu Yingheng1, Chang Shannon1, Malter Lisa2, Dikman Andrew3, Hudesman David4 1NYU School of Medicine, New York, New York, 2NYU School of Medicine, New York, New York, 3New York University School of Medicine, New York, New York, 4New York University School of Medicine, New York, New York P-098 Complementary and Alternative Medicine in Brazilian Patients With Inflammatory Bowel Diseases Henriques Débora1; Baima Julio2, de Barros Jaqueline3, Vanni Jeslei1, Oliveira Rebeca1, Lima Henrique4, Otiti Jean4, Neves Fabio4, Sassaki Ligia5, Zaltman Cyrla6 1UNESP, Botucatu, Brazil, 2Faculty of Medicine of Botucatu, Botucatu, Brazil, 3Faculty of Medicine of Botucatu, Botucatu, Brazil, 4UFRJ, Rio de Janeiro, Brazil, 5Unesp- FMB, Botucatu, Brazil, 6Federal University of Rio de Janeiro, Rio de Janeiro, Brazil P-099 Patient-ly Waiting: A Systematic Review of Patient-Centered Access to IBD Care in Canada Mathias Holly1, Veldhuyzen van Zanten Sander2, Kits Olga3, Heisler Courtney1, Jones Jennifer1 1QEII Health Sciences Centre, Halifax, Canada, 2University of Alberta, Edmonton, Canada, 3Nova Scotia Health Authority/Dalhousie University, Halifax, Canada P-100 Venous Thromboembolism Prophylaxis in Hospitalized Patients With Inflammatory Bowel Disease: Are We Falling Short? Delmonico Matthew1, Urbas Ryan2, Huntington William2, Vitorsky Olga2, Canakis Andrew3 1Lankenau Medical Center, Wynnewood, Pennsylvania, 2Lankenau Medical Center, Wynnewood, Pennsylvania, 3Philadelphia College of Osteopathic Medicine, Wynnewood, Pennsylvania P-101 Tolerability of Ustekinumab in Induction and Maintenance for the Treatment of Crohn’s Disease Loftus, Jr Edward1, Sattin Bernie2, Jacobstein Douglas3, Gasink Christopher4, Sloan Sheldon5, Feagan Brian6, Colombel Jean-Frederic7 1Mayo Clinic, Rochester, Minnesota, 2Janssen Inc., Toronto, Canada, 3Janssen Research & Development, LLC, Spring House, Pennsylvania, 4Janssen Research and Development, LLC, Spring House, Pennsylvania, 5Janssen Scientific Affairs, LLC, Horsham, Pennsylvania, 6Robarts Research Institute, University of Western Ontario, London, Canada, 7Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York

P-102 Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately-to-Severely Active Crohn’s Disease Sands Bruce1, Gasink Christopher2, Jacobstein Douglas3, Ott Elyssa4, Lang Yinghua2, Ramachandran Paraneedharan3, Ghosh Subrata5 1Icahn School of Medicine at Mount Sinai, New York, New York, 2Janssen Research and Development, LLC, Spring House, Pennsylvania, 3Janssen Research & Development, LLC, Spring House, Pennsylvania, 4Janssen Scientific Affairs, LLC, Spring House, Pennsylvania, 5University of Birmingham, Birmingham, United Kingdom P-103 Rapidity of Symptomatic Improvement With Vedolizumab Therapy for Active CD: A GEMINI 2 Post Hoc Analysis Feagan Brian1, Lissoos Trevor2, Lasch Karen3, James Alexandra4, Cao Charlie5, Khalid Javaria Mona4, Colombel Jean-Frederic6 1Robarts Research Institute, University of Western Ontario, London, Canada, 2Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 3Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 4Takeda Development Centre Europe, Ltd., London, United Kingdom, 5Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 6Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York

P-104 Vedolizumab Demonstrates Early Symptomatic Improvement in Ulcerative Colitis: A GEMINI 1 Post Hoc Analysis Feagan Brian1, Lasch Karen2, Khalid Javaria Mona3, Cao Charlie4, Wojtowicz Abigail5, James Alexandra3, Colombel Jean-Frederic6 1Robarts Research Institute, University of Western Ontario, London, Canada, 2Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 3Takeda Development Centre Europe, Ltd., London, United Kingdom, 4Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 5Takeda Pharmaceuticals USA, Inc., Deerfield, Illinois, 6Dr. Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York P-105 Etrolizumab Treatment Improves Histologic Activity as Assessed by Both the Robarts Histopathology and Nancy Histological Indices Peyrin-Biroulet Laurent1, Feagan Brian2, De Hertogh Gert3, Rubin David T.4, Maciuca Romeo5, McBride Jacqueline5; Arulmani Udayasankar5, Scherl Alexis5 1Gastroenterology Unit, Nancy, France, 2University of Western Ontario, London, Canada, 3University of Leuven, Leuven, Belgium, 4University of Chicago Medicine, Chicago, Illinois, 5Genentech, Inc., South San Francisco, California

P-106 Long, Non-coding RNA Gene Expression Signatures to Distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease Spurlock, III Charles1, Tossberg John2, Shaginurova Guzel1, Harmata Andrew2, Crooke, III Philip3, Aune Thomas4 1IQuity, Inc./Vanderbilt University School of Medicine, Nashville, Tennessee, 2IQuity, Inc., Nashville, Tennessee, 3IQuity, Inc./Vanderbilt University, Nashville, Tennessee, 4IQuity, Inc./Vanderbilt University School of Medicine, Nashville, Tennessee P-107 Efficacy of Quantitated Autofluorescence Imaging Endoscopy in Patients With Ulcerative Colitis: A Multicenter Study Moriichi Kentaro1, Fujiya Mikihiro1, Sugiyama Yuya1, Iwama Takuya1, Ijiri Masami1, Tanaka Kazuyuki1, Takahashi Keitaro1, Sakatani Aki1, Ando Katsuyoshi1, Nomura Yoshiki1, Ueno Nobuhiro1, Kashima Shin1, Inaba Yuhei2, Ito Takahiro3, Okumura Toshikatsu1 1Asahikawa Medical University, Asahikawa, Japan, 2Asahikawa City Hospital, Asahikawa, Japan, 3Asahikawa Kousei Hospital, Asahikawa, Japan P-108 Therapeutic Drug Monitoring of the Biosimilar SB2 (RENFLEXIS™, Infliximab-abda) Using LabCorp Infliximab Assays for Drug Level and Anti-drug Antibodies Chun Kelly1, Garcia Gonzalez Zonia2, Yang Jane1 1LabCorp, Calabasas, California, 2LabCorp, Calabasas, California P-109 Use of Therapeutic Drug Monitoring (TDM) to Aid Treatment Decision Making: A Retrospective View From a Large Community Practice Fourment Chris, Pieper Alexander, Ritter Tim Texas Digestive Disease Consultants, Southlake, Texas P-110 Diagnostic Performance of Zinc Protoporphyrin/Heme Ratio in Screening of Anemia and Non-anemic Iron Deficiency in Patients With Inflammatory Bowel Disease Aksan Ayşegül1, Leventi Lena2, Radeke Heinfried3, Dignass Axel4; Stein Jürgen5 1Hacettepe University, Ankara, Turkey, 2DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 3Goethe University Frankfurt, Frankfurt/Main, Germany, 4Agaplesion Markus Krankenhaus, Frankfurt, Frankfurt/Main, Germany, 5Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany P-111 YI Vedolizumab Trough Levels in Inflammatory Bowel Disease: Initial Clinical Experience Al-Bawardy Badr, Piovezani Ramos Guilherme, Loftus, Jr Edward Mayo Clinic, Rochester, Minnesota

P-112 YI Use of High Resolution Anorectal Manometry in UC Patients in Remission With Persistent Anorectal Symptoms San Vicente Parada Elias, Gonzàlez Martinez Marina, Mayoral Zavala Arturo 1H. de Especialidades, Centro Medico Nacional sXXI, IMSS, Mexico City, Mexico P-113 Clinical significance of Anti-neutrophil Cytoplasmic Antibodies to Proteinase-3 (PR3-ANCA) in Patients With Ulcerative Colitis Hamada Kensuke1, Yoshino Takuya2, Sono Makoto1, Yazumi Shujiro1 1Kitano Hospital, Osaka, Japan, 2Kyoto University, Graduate School of Medicine, Kyoto, Japan P-114 YI IBD – Is It a Risk Factor for the Diagnosis of Hepatic Steatosis? Arieira Cátia1, Monteiro Sara2, Xavier Sofia3, Dias de Castro Francisca4, Magalhães Joana5, Marinho Carla6, Cotter José4 1Hospital da Senhora da Oliveira , Guimarães, Portugal, 2Gastroenterology Department, Hospital Senhora da Oliveira-Guimarães, Guimarães, Portugal, 3Hospital da Senhora da Oliveira , Guimarães, Portugal, 4Gastroenterology Department, Hospital Senhora da Oliveira-Guimarães, Guimarães, Portugal, 5Gastroenterology Department, Hospital da Senhora da Oliveira-Guimarães, Guimarães, Portugal, 6Hospital da Senhora da Oliveira, Guimarães, Portugal P-115 YI Is Contrast-Enhanced Ultrasonography the Best Non-invasive Method to Evaluate Ileal Crohn’s Disease Activity? Monteiro Sara, Dias de Castro Francisca, Leite Sílvia, Magalhães Joana, Moreira Maria João, Cotter José Gastroenterology Department, Hospital Senhora da Oliveira-Guimarães, Guimaraes, Portugal P-116 Faecals Extracts Biomarkers in IBD Patients: Is It Useful? Neto Manoel Federal University of Alagoas, Maceio, Brazil P-117 YI Level of Antibodies to Type I Collagen in Ulcerative Colitis Mukhametova Dilyara1, Abdulganieva Diana1, Zinkevich Oleg2, Saphina Nellya2, Koporulina Marina2, Odintsova Alfiya3 1Kazan State Medical University, Kazan, Russia, 2Kazan State Medical Academy, Kazan, Russia,

3Republican Clinical Hospital, Kazan, Russia P-118 Factors Influencing Best Practices in Treating IBD: Results From a Predictive Modeling Analysis of Educational Outcomes Data Reiter Jamie, Perez Jan, Tordoff Sharon, Faler Whitney CME Outfitters, LLC, Bethesda, Maryland P-119 Red Blood Cell Distribution Width and It's Association With Inflammatory Bowel Disease Management Strauss Alexandra1; Rosario Michelle2, Patel Harsh3, Caire Michael4, Kumar Ambuj5, Brady Patrick6 1Johns Hopkins, Baltimore, Maryland, 2University of South Florida, Tampa, Florida, 3University of South Florida Morsani College of Medicine, Tampa, Florida, 4TGH Transplant & Specialty Services, Tampa, Florida, 5University of South Florida, Tampa, Florida, 6USF Health Division of Digestive Diseases and Nutrition, Tampa, Florida P-120 Pseudopolyposis: A Manifestation of Isolated Upper Gastrointestinal Crohn’s Disease Aggarwal Soorya1, Cavanagh Yana2, Shulik Oleg3, Grossman Matthew4, Galeano Narmer4 1Lehigh Valley Health Network at Cedar Crest, Allentown, Pennsylvania, 2New York Medical College at St. Joseph's Regional Medical Center, Paterson, New Jersey, 3Georgetown University Hospital, Washington, District of Columbia, 4St. Joseph’s Regional Medical Center, Paterson, New Jersey P-121 Ileal Pouch of Ulcerative Colitis Patients Exhibit Impaired Autophagy Paiva Nielce1, Pascoal Livia1, Negreiros Leandro1, Portovedo Mariana1, Coope Andressa1, Ayrizono Maria de Lourdes2, Coy Claudio1, Milanski Marciane1; Leal Raquel1 1University of Campinas, Campinas, Brazil, 2Unicamp, Campinas, Brazil P-122 Preoperative Serum Vedolizumab Levels Do Not Impact Postoperative Outcomes in Inflammatory Bowel Disease (IBD) Lopez Nicole1, Zaghiyan Karen2, Melmed Gil3, McGovern Dermot3, Jain Anjali4, Landers Carol1, Fleshner Phillip3 1Cedars-Sinai, Los Angeles, California, 2Cedars Sinai Medical Center, Los Angeles, California, 3Cedars Sinai Medical Center, Los Angeles, California, 4Prometheus Labs Inc., San Diego, California

P-123 Comparison of the Expression of Metalloproteinases and Their Tissue Inhibitors in Ulcerative Colitis and Colon Diverticulitis Nemeth Zoltan1, Barratt-Stopper Patricia1, Hakakian Daniel2, Rolandelli Rolando3 1Morristown Medical Center, Department of Surgery, Morristown, New Jersey, 2Morristown Medical Center, Morristown, New Jersey, 3Morristown Medical Center, Department of Surgery, Morristown, New Jersey P-124 The Efficacy and Safety of Infliximab in Pediatric Crohn’s Disease in China Wang Xiongqiong1, Xu Chundi2, Hu Hui3, Xiao Yuan4, Yu Yi5, Zhang Ting3 1Shanghai Ruijin Hospital, Shanghai, China, 2Shanghai Ruijin Hospital, Shanghai, China, 3Department of Gastroenterology, Children Hospital of Shanghai, Shanghai Jiao Tong University, School of Medicine, Shanghai, China, 4Shanghai Ruijin Hospital, Shanghai, China, 5Shanghai Ruijin Hospital, Shanghai, China P-125 Anaerobic Stool Preparation Method for Fecal Microbiota Transplantation Is Not Superior to Conventional Aerobic Method in Preserving Anaerobic Bacteria Shimizu Hirotaka1, Arai Katsuhiro1, Takeuchi Ichiro1, Takahashi Takuya2, Asahara Takashi2, Tsuji Hirokazu2, Matsumoto Satoshi2, Yamashiro Yuichiro3 1National Center for Child Health and Development, Setagaya, Japan, 2Yakult Central Institute, Kunitachi-shi, Japan, 3Probiotics Research, Juntendo University Graduate School of Medicine, Bukyo-ku, Japan P-126 MK2 Kinase Activity Is Required To Restore Intestinal Homeostasis After Damage Suarez-Lopez Lucia1, Merrick Karl2, Morandell Sandra1, Hernandez Yuliana3, Villablanca Eduardo4, Haigis Kevin5, Yaffe Michael1 1Massachusetts Institute of Technology, Cambridge, Massachusetts, 2Massachusetts Institute of Technology, Cambridge, Massachusetts, 3Massachusetts Institute of Technology, Cambridge, Massachusetts, 4Karolinska Institute, Stockholm, Sweden, 5Cancer Research Institute, Beth Israel Deaconess Cancer Center and Department of Medicine, Boston, Massachusetts P-127 YI Inflammatory Bowel Disease Nurse in the Follow-Up of Patients From an IBD Program Simian Daniela1, Flores Lilian2, Quera Rodrigo1, Ibáñez Patricio3, Figueroa Carolina4, Lubascher Jaime5, Kronberg Udo6 1Clinica Las Condes, Las Condes, Chile, 2Clínica Las Condes, Santiago, Chile, 3Clinica Las Condes, Santiago, Chile, 4Clinica Las Condes, Santiago, Chile, 5Clínica Las Condes, Santiago, Chile, 6Clinica Las Condes, Las Condes, Chile

P-128 Essential Assessment Templates for IBD RNs Cavanaugh Kati, Prothero Breanne; Winzenburg Patricia, Engen Alicia Mayo Clinic, Rochester, Minnesota P-129 The Initial Dialogue as a Basis for Cooperation With the Newly Diagnosed IBD Patient Mikkelsen Else Regionshospitalet Herning, Herning, Denmark P-130 YI Fecal Transplant in Inflammatory Bowel Disease- 2 Year Retrospective Analysis Flowers Jeremy University of California San Diego, San Diego, California P-131 YI Health-Related Quality of Life Among Patients With and Without Inflammatory Bowel Disease Kamp Kendra, Stommel Manfred Michigan State University, East Lansing, Michigan